Hugel Holds '2021 Online Kickoff Meeting' for Employees

[Asia Economy Reporter Hyunseok Yoo] Hugel, a global total medical aesthetic specialist company, announced on the 8th that it held the ‘2021 Kick off meeting’ for all employees to welcome the new year.

To prevent the spread of COVID-19, the event was held online in a non-face-to-face format and started with a New Year's address by CEO Executive Officer Jihoon Son. This was followed by a time to share Hugel’s goals and vision for its 20th anniversary this year, as well as the business plans for the year to achieve them.

Hugel aims to achieve annual sales of 1 trillion KRW by 2025. Leading with the Chinese market, where it has completed the launch of the botulinum toxin product ‘Letybo (export name)’ and is about to begin full-scale distribution through its Chinese partner Sihuan Pharmaceutical, the company explained its blueprint for entering and successfully establishing itself in major botulinum toxin markets such as Europe and the United States. In addition, as the number one company in the domestic botulinum toxin and HA filler market, Hugel shared business plans to further solidify its position in existing markets and to leap forward as a ‘medical aesthetic specialist company.’

Along with the announcement of Hugel’s macro business plans, detailed plans by each headquarters and business division for more efficient and organic cooperation from product development and production to subsequent sales and marketing were presented. Besides the business plan presentations, the ‘Hugel 30-second Video Contest’ involving Hugel employees was also held. Previously, to commemorate its 20th anniversary, Hugel held a contest for all employees to submit 30-second videos themed around ‘20.’

A Hugel official said, “This year marks the monumental 20th anniversary of Hugel’s founding, and all employees will unite with the goal of leaping forward as a ‘global company.’ Based on excellent product quality and aggressive marketing activities, we plan to fulfill our role and responsibility as a leading company that can promote the excellence of K-bio not only domestically but also in the global market.”

This content was produced with the assistance of AI translation services.